295-OR: The PNPLA3 G-allele Reduces the Beneficial Effects of a Healthy Diet on Hepatic Lipid Content in Type 2 Diabetes
Kalliopi Pafili(Düsseldorf University Hospital), Michael Roden(Düsseldorf University Hospital), Birgit Knebel(Hochschule Düsseldorf University of Applied Sciences), Maximilian Huttasch(Deutsches Diabetes-Zentrum e.V.), Klaus Straßburger(Deutsches Diabetes-Zentrum e.V.), Stefan Kabisch(Deutsches Diabetes-Zentrum e.V.), Oana‐Patricia Zaharia(Düsseldorf University Hospital), ALEXANDER STROM, Yanislava Karusheva(Deutsches Diabetes-Zentrum e.V.), Julia Szendroedi(Hochschule Düsseldorf University of Applied Sciences), CHRISTIAN HERDER(Hochschule Düsseldorf University of Applied Sciences)
Cited by 0
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
The integrative biology of type 2 diabetes
|Nature|2019|1.1k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Annals of Hepatology|2023|789